The design strategy for pillararene based active targeted drug delivery systems

Area of Science:

• Supramolecular Chemistry
• Nanotechnology
• Oncology

Background:

• Pillararenes possess unique columnar architectures and electron-rich cavities, enabling versatile host-guest complexation.
• Their structural modifiability allows integration into advanced drug delivery systems (DDSs).
• Pillararene-based DDSs are emerging as potent tools for cancer diagnosis and therapy, including chemotherapy, phototherapy, and chemodynamic therapy.

Purpose of the Study:

• To comprehensively summarize design strategies for pillararene-based active targeted DDSs for improved cancer therapy.
• To highlight the integration of tumor-targeting functionalities into pillararene DDSs for precise drug delivery.
• To classify and discuss the strengths and weaknesses of different targeting approaches.

Main Methods:

• Reviewing current literature on pillararene-based active targeted DDSs.
• Classifying DDS designs into three main categories: host-guest complexation, charge reversal, and targeted group modification.
• Analyzing specific examples to illustrate the efficacy and limitations of each strategy.

Main Results:

• Pillararene-based DDSs can be engineered with tumor-targeting groups to achieve precise drug delivery at cancer sites.
• Active targeting significantly enhances the efficacy of cancer therapies.
• Three primary design strategies (host-guest complexation, charge reversal, targeted group modification) offer distinct advantages and disadvantages.

Conclusions:

• Pillararene-based active targeted DDSs represent a significant advancement in precision oncology.
• The structural versatility of pillararenes facilitates the development of sophisticated targeted delivery platforms.
• Further research into these strategies promises to optimize cancer treatment outcomes.